A detailed history of Brown Brothers Harriman & CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 777 shares of BSX stock, worth $69,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
777
Previous 840 7.5%
Holding current value
$69,821
Previous $64,000 1.56%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $4,596 - $5,292
-63 Reduced 7.5%
777 $65,000
Q1 2024

May 10, 2024

SELL
$57.6 - $68.62 $18,432 - $21,958
-320 Reduced 27.59%
840 $57,000
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $12,111 - $14,394
249 Added 27.33%
1,160 $67,000
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $50,190 - $54,680
-1,000 Reduced 52.33%
911 $48,000
Q2 2023

Aug 07, 2023

SELL
$49.72 - $54.64 $49,720 - $54,640
-1,000 Reduced 34.35%
1,911 $103,000
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $15,871 - $17,610
352 Added 13.76%
2,911 $145,000
Q4 2022

Feb 09, 2023

BUY
$39.56 - $47.22 $80,188 - $95,714
2,027 Added 381.02%
2,559 $118,000
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $478,441 - $1.43 Million
-13,033 Reduced 96.08%
532 $21,000
Q2 2022

Aug 11, 2022

BUY
$35.24 - $47.1 $3,559 - $4,757
101 Added 0.75%
13,565 $506,000
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $1,636 - $1,804
40 Added 0.3%
13,464 $596,000
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $24,821 - $29,255
652 Added 5.1%
13,424 $570,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $524,198 - $583,318
12,714 Added 21920.69%
12,772 $554,000
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $319,056 - $365,864
-8,270 Reduced 99.3%
58 $2,000
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $9,205 - $10,353
261 Added 3.24%
8,328 $322,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $23,403 - $29,630
-706 Reduced 8.05%
8,067 $290,000
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $14,602 - $17,905
424 Added 5.08%
8,773 $335,000
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $1,267 - $1,642
42 Added 0.51%
8,349 $293,000
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $1,265 - $2,239
49 Added 0.59%
8,307 $271,000
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $226,689 - $271,584
5,986 Added 263.47%
8,258 $373,000
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $6,691 - $7,212
166 Added 7.88%
2,272 $92,000
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $73,520 - $90,515
2,106 New
2,106 $91,000
Q1 2018

May 14, 2018

SELL
$25.2 - $28.54 $2,797 - $3,167
-111 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $2,751 - $3,307
111
111 $3,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.